Selective neuronal vulnerability in Parkinson's disease

被引:46
|
作者
Gonzalez-Rodriguez, Patricia [1 ]
Zampese, Enrico [1 ]
Surmeier, D. James [1 ]
机构
[1] Northwestern Univ, Feinberg Sch Med, Dept Physiol, Chicago, IL 60611 USA
来源
RECENT ADVANCES IN PARKINSON'S DISEASE | 2020年 / 252卷
关键词
Parkinson's disease; Neurodegeneration; Axon; Mitochondrial dysfunction; Oxidant stress; Calcium; alpha-synuclein; Synapse; Lewy pathology; Propagation; Aging; MITOCHONDRIAL OXIDANT STRESS; MUTANT ALPHA-SYNUCLEIN; DORSAL MOTOR NUCLEUS; DOPAMINE-CONTAINING NEURONS; SUBSTANTIA-NIGRA NEURONS; LOCUS-COERULEUS NEURONS; LEWY BODY; COMPLEX-I; PACEMAKER ACTIVITY; PEDUNCULOPONTINE NUCLEUS;
D O I
10.1016/bs.pbr.2020.02.005
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Parkinson's disease (PD) is the second most common neurodegenerative disease, disabling millions worldwide. Despite the imperative PD poses, at present, there is no cure or means of slowing progression. This gap is attributable to our incomplete understanding of the factors driving pathogenesis. Research over the past several decades suggests that both cell-autonomous and non-cell autonomous processes contribute to the neuronal dysfunction underlying PD symptoms. The thesis of this review is that an intersection of these processes governs the pattern of pathology in PD. Studies of substantia nigra pars compacta (SNc) dopaminergic neurons, whose loss is responsible for the core motor symptoms of PD, suggest that they have a combination of traits-a long, highly branched axon, autonomous activity, and elevated mitochondrial oxidant stress-that predispose them to non-cell autonomous drivers of pathogenesis, like misfolded forms of alpha-synuclein (alpha-SYN) and inflammation. The literature surrounding these issues will be briefly summarized, and the translational implications of an intersectional hypothesis of PD pathogenesis discussed.
引用
收藏
页码:61 / 89
页数:29
相关论文
共 50 条
  • [1] Neuronal vulnerability, pathogenesis, and Parkinson's disease
    Sulzer, David
    Surmeier, D. James
    MOVEMENT DISORDERS, 2013, 28 (06) : 715 - 724
  • [2] On Cell Loss and Selective Vulnerability of Neuronal Populations in Parkinson's Disease
    Giguere, Nicolas
    Nanni, Samuel Burke
    Trudeau, Louis-Eric
    FRONTIERS IN NEUROLOGY, 2018, 9
  • [3] Selective neuronal vulnerability in Parkinson disease
    Surmeier, D. James
    Obeso, Jose A.
    Halliday, Glenda M.
    NATURE REVIEWS NEUROSCIENCE, 2017, 18 (02) : 101 - 113
  • [4] Neuronal Vulnerability, Pathogenesis, and Parkinson's Disease
    Sulzer, David
    Surmeier, D. James
    MOVEMENT DISORDERS, 2013, 28 (01) : 41 - 50
  • [5] Calcium, cellular aging, and selective neuronal vulnerability in Parkinson's disease
    Surmeier, D. James
    Guzman, Jaime N.
    Sanchez-Padilla, Javier
    CELL CALCIUM, 2010, 47 (02) : 175 - 182
  • [6] Calcium, Bioenergetics, and Neuronal Vulnerability in Parkinson's Disease
    Surmeier, D. James
    Schumacker, Paul T.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2013, 288 (15) : 10736 - 10741
  • [7] Molecular determinants of selective dopaminergic vulnerability in Parkinson's disease: an update
    Brichta, Lars
    Greengard, Paul
    FRONTIERS IN NEUROANATOMY, 2014, 8
  • [8] Neuronal Vulnerability to Degeneration in Parkinson's Disease and Therapeutic Approaches
    Sharma, Tanushree
    Kumar, Rajnish
    Mukherjee, Sayali
    CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2024, 23 (06) : 715 - 730
  • [9] Vulnerability of mesostriatal dopaminergic neurons in Parkinson's disease
    Gonzalez-Hernandez, Tomas
    Cruz-Muros, Ignacio
    Afonso-Oramas, Domingo
    Salas-Hernandez, Josmar
    Castro-Hernandez, Javier
    FRONTIERS IN NEUROANATOMY, 2010, 4
  • [10] Neuromelanin, aging, and neuronal vulnerability in Parkinson's disease
    Vila, Miquel
    MOVEMENT DISORDERS, 2019, 34 (10) : 1440 - 1451